Search for: "NATIONAL LEGISLATIVE ASSOCIATION ON PRESCRIPTION DRUG PRICES" Results 21 - 40 of 105
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2015, 5:00 am
National Drug Co., 23 A.2d 743 (Pa. 1942), long before the concept of §402A strict liability in tort was even a gleam in a plaintiff’s lawyer’s eye. [read post]
2 Jun 2023, 2:50 am by Kurt R. Karst
  Nevertheless, riding on the wave of drug price transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drug price transparency reporting. [read post]
12 Jan 2010, 3:58 pm
Expanding the exclusivity period is vitally important, since it removed the barrier to entry that has protected collusive settlements between brands and first-filing generics.The letter was signed by AAI, Consumers Union, Families USA, The National Association on Prescription Drug Prices, Consumer Federation of America, US PIRG, and Community Catalyst. [read post]
26 Sep 2018, 6:30 am by Michael B. Stack
  The legislation that took effect in December 2014 capped prices paid for physician-dispensed drugs and restricted physician’s ability to dispense opioids and other drugs to limited timeframes. [read post]
30 Apr 2012, 4:10 am by David J. DePaolo
Though Connecticut has a fee schedule, adopted in 2000, that caps the price of prescription drugs at the average wholesale price established by Medi-Span plus a $5 dispensing fee for brand-name mediation and $8 for generic drugs, doctors are buying prescriptions from drug repackagers, which are allowed to assign a new National Drug Code to the drugs they sell doctors and assign their own AWP. [read post]
25 Apr 2016, 7:13 am by Robert Kraft
  They question why Congress hasn’t taken legislative action to improve the system and protect the American public from price gouging. [read post]
22 May 2023, 7:46 am by Constance A. Wilkinson
For example, Representative Buddy Carter (R-GA) recently introduced legislation, Drug Price Transparency in Medicaid Act (H.R. 1613), to impose a federal ban on spread pricing in Medicaid managed care and require pharmacies to be reimbursed a minimum of a drug’s national average drug acquisition cost (“NADAC”).[15] CMS establishes NADAC—a federal pricing benchmark utilized by CMS for Medicaid… [read post]
2 Mar 2020, 11:04 am by Cynthia Marcotte Stamer
Currently, insured plans covered by the MLR rule as well as the PBM arrangements of many self-insured, employer or union sponsored health plans, do not require PBMs to disclose, account for, or pass through to the health plan they are engaged by the prescription drug rebates and certain other amounts that PBMs receive and retain from prescription drug manufacturers that the PBM selects for inclusion on the health plan formulary. [read post]
23 Aug 2009, 6:42 pm by Sheri Abrams
More than 32 million people are in the Medicare prescription drug program. [read post]
11 Jun 2019, 5:41 am by Courtenay C. Brinckerhoff
Francer, the draft bill would promote patent thickets, stifle innovation, and undermine Congressional efforts to control prescription drug costs. [read post]
22 Jan 2013, 6:00 am by Michael B. Stack
   News From Gould & Lamb   Gould & Lamb Announces New Relationship With Corporate Pharmacy Services    Now more than ever, a competent and comprehensive prescription drug management program is invaluable. [read post]
6 Mar 2023, 5:16 am by Justin Sherman
These regulations established national privacy and security standards related to electronic health information. [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and briefs amici curiae were referred to the circuit judges who are authorized to request a poll on whether to rehear the appeal en banc. [read post]
31 Jan 2013, 7:54 am by Kelly Buchanan
  For prescription drugs, the relevant law is the Federal Food, Drug, and Cosmetic Act (FD&C Act) (contained in Title 21 of the U.S. [read post]
10 Jan 2011, 5:54 am by FDABlog HPM
PIRG, and the National Legislative Association on Prescription Drug Prices) also urges the U.S. [read post]
11 Dec 2014, 6:00 am by Maira Sutton
Sincerely, International: Article 19 Creative Commons Consumers International Oxfam International SumOfUs Australia: Australian Digital Alliance Australian Fair Trade and Investment Network (AFTINET) Australian Library and Information Association (ALIA) Australian Libraries Copyright Committee (ALCC) Electronic Frontiers Australia (EFA) Public Health Association of Australia (PHAA) Canada: Council of Canadians Canadian HIV/AIDS Legal Network (Réseau juridique canadien… [read post]
2 Mar 2020, 7:29 am by Cynthia Marcotte Stamer
  Among other things, the Proposed Rule, if adopted as proposed, would: Repeal regulations relating to the Early Retiree Reinsurance Program; Require health plans in state insurance markets to count drug rebates and price concessions retained by pharmacy benefit managers (PBMs) as administrative expenses. [read post]
25 Mar 2020, 12:21 pm by Margaret Taylor, Benjamin Wittes
The relevant crimes include price fixing, bid-rigging, and customer and territorial allocation, and are normally subject to a five-year statute of limitations. [read post]